Solactive Pharma Breakthrough Value Index
Solactive Pharma Breakthrough Value Index aims to track the performance of a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. The index is calculated as a net total return index and denominated in US Dollar.
Master Data
| ISIN: | DE000SLA30N4 |
| Bloomberg Ticker: | SOLBIOT Index |
| WKN: | SLA30N |
Current Quotes
| Last quote (12 Jan 2026): | 471.54 |
| Day range: | 471.14 / 472.08 |
| Change abs./rel.: | 0.51 / 0.11% |
| Year range: | 313.60 / 474.44 |
| Name | Index Shares |
|---|---|
| BASILEA PHARMACEUTICA LTD | 0.197217 |
| MESOBLAST LIMITED SPONSORED ADR | 0.804873 |
| ALNYLAM PHARMACEUTICALS INC | 0.025624 |
| BRIDGEBIO PHARMA INC | 0.216975 |
| NIPPON SHINYAKU CO LTD | 0.517134 |
| KYOWA KIRIN CO LTD | 0.650168 |
| IPSEN SA | 0.082237 |
| ARGENX SE - ADR | 0.015427 |
| BIOGEN INC | 0.082335 |
| IONIS PHARMACEUTICALS INC | 0.189158 |
| HALOZYME THERAPEUTICS INC | 0.154572 |
| LG CHEM LTD | 0.05867 |
| BEONE MEDICINES LTD-ADR | 0.033886 |
| MIRUM PHARMACEUTICALS INC | 0.152276 |
| PTC THERAPEUTICS INC | 0.202272 |
| EISAI | 0.331602 |
| BIOMARIN PHARMACEUTICAL INC | 0.200487 |
| PHARMING GROUP NV | 7.679735 |
| ROYALTY PHARMA PLC- CL A | 0.321101 |
| INNOCARE PHARMA LTD | 5.101595 |
| INCYTE CORP | 0.133681 |
| ZEVRA THERAPEUTICS INC | 1.294091 |
| UNITED THERAPEUTICS CORP | 0.028918 |
| TRAVERE THERAPEUTICS INC | 0.535218 |
| SWEDISH ORPHAN BIOVITRUM AB | 0.392792 |
| AGIOS PHARMACEUTICALS INC | 0.321636 |
| CHUGAI PHARMACEUTICAL CO LTD ORD | 0.257512 |
| PHARMA MAR SA | 0.111634 |
| ULTRAGENYX PHARMACEUTICAL INC | 0.363989 |
| XENCOR INC | 1.354634 |
| XERIS BIOPHARMA HOLDINGS INC | 1.475429 |
| ZAI LAB LTD | 0.376532 |
| CATALYST PHARMACEUTICALS INC | 0.570829 |
| GENMAB A/S | 0.042062 |
| VERTEX PHARMACEUTICALS INC | 0.029239 |
| LIGAND PHARMACEUTICALS INC | 0.069458 |